Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.43 |
| ▸ | NR2F2 | P24468 | 1/20 | 0.43 |
| ▸ | RAB9A | P51151 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 3/20 | 0.41 |
| ▸ | CXCR4 | P61073 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 3/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | SLC12A2 | P55011 | 1/20 | 0.39 |
| ▸ | SLC12A5 | Q9H2X9 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL965091 | 0.81 | KMT2A (0.46) | ALDH1A1SMN1; SMN2NR2F2RAB9ALMNA | |
| SCHEMBL2275992 | 0.80 | LMNA (0.42) | ALDH1A1SMN1; SMN2LMNAKMT2AMEN1 | |
| SCHEMBL14097842 | 0.79 | ESR1 (0.43) | SMN1; SMN2RAB9AKMT2AGAA | |
| SCHEMBL10855433 | 0.78 | SLC12A2 (0.51) | ALDH1A1SMN1; SMN2NR2F2RAB9AKMT2A | |
| SCHEMBL8763564 | 0.77 | MEN1 (0.46) | ALDH1A1SMN1; SMN2LMNAKMT2AMEN1 | |
| SCHEMBL8024954 | 0.77 | KMT2A (0.48) | ALDH1A1KMT2AMEN1HTT | |
| SCHEMBL5070898 | 0.77 | ALDH1A1 (0.50) | ALDH1A1SMN1; SMN2LMNAKMT2AMEN1 | |
| SCHEMBL24763632 | 0.76 | SMN1; SMN2 (0.50) | ALDH1A1SMN1; SMN2RAB9ALMNAMAPT | |
| SCHEMBL15371049 | 0.76 | ALDH1A1 (0.42) | ALDH1A1SMN1; SMN2RAB9ALMNAKMT2A | |
| SCHEMBL2184433 | 0.76 | SMN1; SMN2 (0.50) | ALDH1A1SMN1; SMN2RAB9ALMNAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7365215-B2 | Process for preparing 4-aminotetrahydropyran compound and an acid salt thereof, synthetic intermediate thereof and process for preparing the same | UBE INDUSTRIES, LTD. (JP) | 2008-04-29 | — | — | US | disclosed |
| US-20070106083-A1 | Process for preparing 4-aminotetrahydropyran compound and an acid salt thereof, synthetic intermediate thereof and process for preparing the same | UBE INDUSTRIES, LTD. (JP) | 2007-05-10 | — | — | US | disclosed |
| EP-1661894-A1 | PROCESS FOR PRODUCTION OF 4-AMINOTETRAHYDROPYRANS AND SALTS THEREOF WITH ACIDS, INTERMEDIATES FOR THE PROCESS, AND PROCESS FOR PRODUCTION THEREOF | Ube Industries, Ltd. (JP) | 2006-05-31 | — | — | EP | disclosed |
| EP-1247807-B1 | PROCESSES FOR PRODUCING TETRAHYDROPYRANYL-4-SULFONATE AND 4-AMINOTETRAHYDROPYRAN COMPOUND | UBE INDUSTRIES (JP) | 2004-04-28 | — | — | EP | disclosed |
| US-6653489-B2 | Reacting 3-buten-1-ol with a formaldehyde compound and an organic sulfonic acid | UBE INDUSTRIES, INC. (JP) | 2003-11-25 | — | — | US | disclosed |
| US-20030004359-A1 | Processes for producing tetrahydropyranyl-4-sulfonates and 4-aminotetrahydropyran compound | UBE INDUSTRIES, LTD. (JP) | 2003-01-02 | — | — | US | disclosed |
| EP-1247807-A1 | PROCESSES FOR PRODUCING TETRAHYDROPYRANYL-4-SULFONATE AND 4-AMINOTETRAHYDROPYRAN COMPOUND | Ube Industries, Ltd. (JP) | 2002-10-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030004359-A1 | Processes for producing tetrahydropyranyl-4-sulfonates and 4-aminotetrahydropyran compound | HPD, DHPS, FDPS | ALDH1A1 158/4885SMN1; SMN2 3422/4885NR2F2 3330/4885 |
| US-20070106083-A1 | Process for preparing 4-aminotetrahydropyran compound and an acid salt thereof, synthetic intermediate thereof and process for preparing the same | PAH, HPD, REN | ALDH1A1 875/4885SMN1; SMN2 3594/4885NR2F2 1273/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.